Transgenomic sells Wave System to Genzyme

Apr 23, 2001

NEW YORK, April 23 – Transgenomic has sold its Wave genetic analysis system to biotechnology giant Genzyme, the companies said Monday.

Genzyme will use the system in its research on genetic mutations that cause or are associated with hereditary diseases such as lysosomal storage disorders and some cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Main menu